NCT05506319

Hypotension in the Weaning From Vasopressor Drugs

Incidence of Hypotension in the Weaning From Vasopressor Drugs

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 78 (actual)
• Sponsor: Hospital Nossa Senhora da Conceicao · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Although there is consensus in the literature on hemodynamic management of septic shock in the resuscitation phase, the best way to conduct the weaning of vasopressor drugs in the stabilization phase remains open. The present study aims to study the incidence of hypotension in the weaning phase of vasopressor drugs- norepinephrine and vasopressin.

Detailed description

A randomized, open-case clinical trial with 2 arms will be conducted: initial suspension of norepinephrine (norepinephrine group) versus initial vasopressin (vasopressin group). The selection of patients who will participate in the study will be for convenience. The randomization of the patients will be done by opaque envelopes 1:1, grouped into blocks, generated by random numbers. The study will be carried out in the intensive care unit of a tertiary hospital in Southern Brazil, taking into account the clinical and surgical patients. In the intensive care unit, after randomization, patients will be identified by posters, attached to the bed. The titration of vasoactive drugs will be criterion of the assistant team.

Conditions

• Septic Shock

Interventions

Type	Name	Description
OTHER	Norepinephrine	The patients will be randomized for the initial suspension of norepinephrine (norepinephrine group).
OTHER	Vasopressin	The patients will be randomized for the initial suspension of vasopressin (vasopressin group).

Timeline

• Start date: 2022-05-01
• Primary completion: 2022-12-01
• Completion: 2023-06-30
• First posted: 2022-08-18
• Last updated: 2025-03-14

Locations

1 site across 1 country: Brazil